Latest / Boardroom Conversations with Fexingo: CEOs, Strategy, and Corporate Leadership Explained / How the Hershey Board Fought Off a Hostile Takeover
Transcript
- Lucas: So on August 10th, Mondelez made a roughly forty-two billion dollar cash and stock bid for Hershey, and the Hershey board rejected it within a week. But the twist is, this wasn't just a board saying no to a lowball offer. This was a board deploying every legal and structural defense available, and it's a masterclass in how to fight a hostile takeover when your company has a soul. Luna: A soul? That's a strong word for a chocolate company. But I get it — Hershey is basically a Pennsylvania institution. What did the board actually do? Lucas: Right, so first, they activated a poison pill — technically a shareholder rights plan — that would dilute any buyer's stake if they crossed a ten percent threshold. That alone doesn't kill the deal, but it signals the board won't roll over. Then they leaned on the Hershey Trust, which controls about eighty-one percent of the voting power, and they made it clear the Trust's charitable mission — funding a school for underprivileged kids in Hershey, Pennsylvania — is not for sale. Luna: And that's where it gets interesting, because the Trust has a fiduciary duty to the school, not just to shareholders. So the board essentially argues they're protecting the mission, not just the stock price. Lucas: Exactly. And look, we should say upfront, this show is ad-free, and that's a choice we make deliberately. If these conversations have moved your work forward in some small way, and you want to support that, the link is buy me a coffee dot com slash fexingo. It keeps us independent, no ads, no sponsors pulling the strings. Luna: Yeah, and honestly, it's the listener support that keeps this going. So if you've gotten value from these episodes, that's the way to help. Lucas: So back to the defense. The board also appealed to Pennsylvania's attorney general, who has oversight over charitable trusts. The AG can weigh in on whether the Trust's involvement in the deal serves the public interest. And that's a powerful tool, because it takes the fight out of the boardroom and into the courts, where a hostile bidder has to prove the deal benefits the community, not just the shareholders. Luna: That's a really specific legal lever. How often do boards actually pull that one? Lucas: Rarely, honestly. Most boards just rely on the poison pill and the 'just say no' defense. But Hershey's structure — the Trust's voting control — makes it uniquely positioned to use the AG as a shield. And it worked. Mondelez walked away on August 18th, saying they wouldn't pursue a hostile path. Luna: So the stock probably took a hit when the deal fell through? I mean, shareholders who wanted a premium must be disappointed. Lucas: Hershey shares dropped about five percent the day Mondelez pulled out. But here's the thing — the board's job isn't to maximize the stock price on any given Tuesday. It's to maximize long-term value, and sometimes that means rejecting a premium that would destroy the company's identity. Luna: But isn't that exactly the kind of thing that gets boards sued? Shareholders claiming the board is acting in its own interest, not theirs. Lucas: That's the key tension. Under Delaware law, which governs most public companies, boards have to show they're acting in the best interest of the corporation, and they can use the 'business judgment rule' to justify rejecting a bid if they have a rational basis. But Hershey is incorporated in Pennsylvania, and the law there is even more protective of boards. Plus, the Trust's control means the board doesn't face the typical proxy fight threat. Luna: So the board isn't just saying no — they're making it structurally impossible for a bidder to win without a long, expensive legal battle. Lucas: Precisely. And that's the lesson for any board facing a hostile bid: you want to make the cost of going hostile so high that the bidder walks away. Mondelez could have taken the fight to the Trust, but they would have had to deal with the AG, the court, and possibly years of litigation. Not worth it for a company that already has its own growth story. Luna: It's interesting how the board framed this as protecting the mission, not just financial metrics. Usually you hear boards talk about 'maximizing shareholder value.' Here they're talking about 'preserving the Hershey legacy.' Lucas: Right, and that's not just PR spin. The board's rejection letter specifically mentioned the Trust's educational mission and the company's commitment to its hometown. That kind of language matters, because it sets up the legal argument: the Trust has a charitable purpose, and a takeover could jeopardize that. It's a defense that works on multiple levels — legal, political, and public opinion. Luna: So if you're a board member at a company with a similar stakeholder structure, what's the takeaway? Is it just 'have a poison pill ready'? Lucas: The poison pill is table stakes. But the deeper lesson is to know your own governance structure inside and out. Hershey's board knew that the Trust's voting power was their ultimate weapon. They also knew that Pennsylvania law gives them more latitude than Delaware. If you're a board, you need to map out all the legal and structural defenses you have before the bid arrives, not during the crisis. Luna: And what about the 'just say no' defense? Is that still viable in 2026? Lucas: It's harder now than it was in the eighties. Courts have chipped away at it, and activist investors have gotten more aggressive. But Hershey proved it can still work if you have the right governance shield. The board didn't just say no — they gave a detailed rationale and showed they had a plan to create value on their own. That's crucial. You can't just reject a bid and do nothing. Luna: So what's Hershey's plan? They must have some organic growth strategy to justify rejecting forty-two billion. Lucas: They've been expanding into salty snacks and international markets, and they've got a new CEO who's focused on cost efficiency and innovation. The board's message is: we can deliver more value over time than a one-time premium. And in this case, the market seems to be giving them the benefit of the doubt — the stock is actually up since the initial bid was announced. Luna: Up even after the deal fell through? That's a vote of confidence. Lucas: It is. And it shows that investors sometimes reward boards that prioritize long-term strategy over short-term payouts. Of course, that could change if the next earnings report disappoints, but for now, the board stands as a good example of how to handle a hostile approach. Luna: One thing I'm curious about — how does the board manage the conflict of interest? The Trust's board members are also on Hershey's board, so they're on both sides of the table. Lucas: That's the elephant in the room. There are overlaps, and critics argue that the Trust's primary duty is to the school, not to Hershey shareholders. But the board has to navigate that by showing that the deal would be bad for the Trust's mission, not just for the company's stock. It's a delicate dance, and it's why the 'conflicted fiduciary' issue is a recurring theme in this kind of defense. Luna: So if you're an investor, is there a lesson here? How do you read a board's rejection letter? Lucas: Look for three things. First, does the board have a credible standalone plan? Second, are they citing specific structural defenses — like a poison pill or a controlled voting structure? Third, are they addressing the stakeholders beyond shareholders? If they just say 'we think the bid undervalues us,' that's weaker than a detailed rebuttal that ties the mission to the company's long-term value. Luna: That makes sense. And I guess the biggest takeaway for me is that a hostile takeover isn't just about the numbers — it's about who controls the narrative and the legal levers. Lucas: Exactly. Hershey's board didn't win because they had the highest math. They won because they had the right structure, the right legal arguments, and the right story. And that's something any board can prepare for in advance. Luna: So what's next for Hershey? Mondelez has said they won't pursue a hostile path, but could they come back with a friendly offer? Lucas: That's always a possibility. Mondelez might wait a year or two, or they might approach the Trust directly. But after a rejection like this, any new bid would have to be significantly higher and probably include assurances about the Trust's mission. The ball is in Hershey's court now. Luna: And if they do come back, the board has already set a precedent for how they'll handle it. Lucas: Absolutely. They've drawn a line in the sand, and that's actually a good thing for investors. It removes uncertainty. You know the board won't sell on the cheap, and you know they're committed to their strategy. That clarity has value in itself. Luna: So, Lucas, if you were on the Hershey board, would you have made the same call? Lucas: I think so, but I'd be nervous about the short-term shareholder backlash. The stock dropped five percent, and some big institutional investors might be frustrated. But in the long run, I believe protecting the mission and the company's independence is the right call — as long as they deliver on their own growth plan. Luna: And that's the gamble, right? The board is essentially betting that they can create more value than a forty-two billion dollar premium. That's a bold bet. Lucas: It is, but it's not just a bet on the stock price. It's a bet on the company's identity and its role in the community. And in this case, the board has the tools to defend that bet. That's the beauty of a well-structured board — it can make decisions that aren't purely financial. Luna: Well, it's definitely a fascinating case study. Thanks for breaking it down, Lucas. Lucas: Anytime. And if you found this useful, we'd love to hear your thoughts. Until next time, keep an eye on the boardroom.